 |  |
| ABX | ||
| 969.904 | ||
| -9.2220 | -0.0094% | |
| BISNIS-27 | ||
| 590.727 | ||
| -6.0140 | -0.0101% | |
| DBX | ||
| 1,973.577 | ||
| -17.4020 | -0.0087% | |
| ECONOMIC30 | ||
| 131.806 | ||
| -1.4680 | -0.0110% | |
| ESGQKEHATI | ||
| 138.932 | ||
| -1.5880 | -0.0113% | |
| ESGSKEHATI | ||
| 138.927 | ||
| -1.5640 | -0.0111% | |
| I-GRADE | ||
| 236.979 | ||
| -2.7580 | -0.0115% | |
| AUDRP | ||
| 10,589.900 | ||
| 46.0000 | 0.4363% | |
| EURRP | ||
| 17,063.500 | ||
| 58.5000 | 0.3440% | |
| JPYRP | ||
| 105.759 | ||
| 0.8310 | 0.7920% | |
| SINRP | ||
| 11,934.300 | ||
| 52.8000 | 0.4444% | |
| USDRP | ||
| 15,480.000 | ||
| 65.0000 | 0.4217% | |
Penelitian terhadap vaksin nasional COVID-19, Vaksin Merah Putih, terus berlanjut, salah satunya oleh tim peneliti Universitas Airlangga bersama PT Biotis Pharmaceutical Indonesia. Penelitian vaksin telah memasuki uji praklinis tahap II.
